Insider · CIK 0001720875
Joel Sendek
Files at CATX (Perspective Therapeutics, Inc.). First filing -, latest -.
In brief
Joel Sendek files SEC Form 4 as CFO at CATX (Perspective Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Joel Sendek has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 4, 2025 | CATX Perspective Therapeutics, Inc. | AGrant or award Stock option (right to buy)derivative | +600,000 | $0.00 | $0 | 600,000 | Sep 5, 2025 |
Questions about Joel Sendek
Answered from the filings on this page, as of the latest one.
Is Joel Sendek buying or selling?
Joel Sendek has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Joel Sendek's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Joel Sendek has 0.
Where does Joel Sendek file Form 4?
Joel Sendek has filed Form 4 at CATX (Perspective Therapeutics, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.